Experiments for taxon Lissoclinum bistratum (DIDEMNIDAE)

Experiments (86 results)

Filters
Worktypes (16)
56
49
15
14
14
13
11
9
8
8
8
3
2
2
1
1
No match
Pharmacology (14)
46
6
6
2
2
2
1
1
1
1
1
1
1
15
No match
Compounds (13)
34
10
10
8
8
3
3
3
3
2
1
1
1
No match
Organisms (8)
43
16
12
6
3
3
2
1
No match
86 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
168001
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
101761
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATAMIDE A
167980
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
101766
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
98785
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167991
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167976
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
98789
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTICRUSTACEAN ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
147602
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
NAIRAIAMIDE A
167997
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167961
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
346833
PHARMACOLOGY OF COMPOUND - IN VIVO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
98778
PHARMACOLOGY OF COMPOUND - IN VIVO
ANESTHETIC ACTIVITY(LOCAL)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167987
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
97914
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167965
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
127417
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Lissoclinum bistratum (DIDEMNIDAE)
CYCLOXAZOLINE
98790
PHARMACOLOGY OF COMPOUND - IN VITRO
FISH POISON
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167983
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167972
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
101760
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATAMIDE A
167970
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
98786
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167969
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167979
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
101763
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATAMIDE B
101769
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATENE B
97915
PHARMACOLOGY OF COMPOUND - IN VITRO
NEUROTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
98775
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167975
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167968
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167996
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
98779
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
138085
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATAMIDE DBISTRATAMIDE C
101770
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATENE B
167964
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167986
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167960
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167989
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167995
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
97913
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
98787
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167971
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
127419
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
CYCLOXAZOLINE
167978
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
101768
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATENE B
101764
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATAMIDE B
98783
PHARMACOLOGY OF COMPOUND - IN VIVO
CHRONOTROPIC EFFECT NEGATIVE
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
168002
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167974
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167981
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
167967
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
98784
PHARMACOLOGY OF COMPOUND - IN VITRO
CARDIOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167992
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
346836
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTITUMOR ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
346835
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTITUMOR ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATAMIDE D
167985
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
98776
PHARMACOLOGY OF COMPOUND - IN VIVOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167999
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167963
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
346831
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167994
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167990
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
101762
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATAMIDE B
98777
PHARMACOLOGY OF COMPOUND - IN VIVO
ANESTHETIC ACTIVITY(LOCAL)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
98782
PHARMACOLOGY OF COMPOUND - IN VIVO
CHRONOTROPIC EFFECT NEGATIVE
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
101767
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
147603
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Lissoclinum bistratum (DIDEMNIDAE)
NAIRAIAMIDE B
98780
PHARMACOLOGY OF COMPOUND - IN VIVOTOXICITY MARKER CODE
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167988
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
167993
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE K
346832
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTITUMOR ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167973
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE C
167982
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
101759
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Lissoclinum bistratum (DIDEMNIDAE)
BISTRATAMIDE A
167962
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
167984
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
101765
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
127418
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
CYCLOXAZOLINE
167998
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
98781
PHARMACOLOGY OF COMPOUND - IN VIVOTOXICITY MARKER CODE
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
98788
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167977
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D
168000
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE A
167966
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE B
346834
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Lissoclinum bistratum (DIDEMNIDAE)
BISTRAMIDE D